It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The purpose of this study was to design silver nanoparticles (AgNPs) poloxamer thermoreversible gel (AgNPs-PL) and investigate whether this gel could provide sustained antibacterial activity against Enterococcus faecalis (E. faecalis) in the root canal. The gels fabricated were characterized in terms of gelatin temperature, particle size, in-vitro Ag+ release, and elemental content. Cytotoxicity of AgNPs-PL on primary human periodontal ligament fibroblasts (HPDLFs) was examined by CCK-8 assay. Characterization of AgNPs-PL gel revealed that it contained particles existing as large clumps/fused aggregates of different shapes, with a mean diameter of 21.624 ± 14.689 nm, exhibited sustained release of Ag+ for 9 days, and non-toxic to HPDLFs at a low dose (4–32 μg/mL) through 24, 48, and 72 h exposures. The antibacterial effect of 16 and 32 μg/mL concentrations of AgNPs-PL was compared with blank poloxamer gel (PL) and calcium hydroxide (CH) using three methods: (I) agar counting plate, (II) scanning electron microscope (SEM) observations, and (III) confocal laser scanning microscope (CLSM) analysis. AgNPs-PL at the two doses above was more effective than PL and CH in removing E. faecalis biofilm at 1, 3, 9 days. Thus, AgNPs-PL exhibits strong activity against E. faecalis and is easy to produce, with a continuous release profile of Ag+. AgNPs-PL gel may be a candidate for a new root canal disinfection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Medical School of Nanjing University, Nanjing Stomatological Hospital, Nanjing, People’s Republic of China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Nanjing Stomatological Hospital, Medical School of Nanjing University, Central Laboratory of Stomatology, Nanjing, People’s Republic of China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
2 Nanjing Stomatological Hospital, Medical School of Nanjing University, Central Laboratory of Stomatology, Nanjing, People’s Republic of China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
3 Medical School of Nanjing University, Nanjing Stomatological Hospital, Nanjing, People’s Republic of China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Nanjing Stomatological Hospital, Medical School of Nanjing University, Central Laboratory of Stomatology, Nanjing, People’s Republic of China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Nanjing Stomatological Hospital, Department of Endodontology, Nanjing, People’s Republic of China (GRID:grid.41156.37)